Scotto G, Savastano A M, Forcella M, Tantimonaco G, Amato G, Salatino G, Pappani A, Stella I
Divisione Malattie Infettive, CORR Foggia, Italy.
Nephron. 1992;61(3):320-1. doi: 10.1159/000186922.
HCV is seen as an emergent problem in Dialysis Units; in fact, the patients of these centers are at high risk for blood-transmitted infections, through coming microepidemies. For this reason and using the same method, we have studied the prevalence of anti-HCV and virus-derived hepatitis in a dialytic population of 105 patients. The prevalence of anti-HCV was 25.71%.
丙型肝炎病毒(HCV)在透析单位被视为一个新出现的问题;事实上,这些中心的患者因不断出现的小规模流行而面临血源性感染的高风险。出于这个原因并采用相同的方法,我们研究了105名透析患者群体中抗丙型肝炎病毒(anti-HCV)和病毒源性肝炎的患病率。抗丙型肝炎病毒的患病率为25.71%。